Anne-Marie Larose holds a Master’s and a Doctoral degree in molecular and cellular biology from Université Laval and a Master’s degree in bio-industries from Université du Québec à Montréal. Ms. Larose began her career by participating in the startup, Geneka Biotechnology. She then worked as the commercial attaché to the Consulate of Great Britain in life sciences and biotechnologies and was a senior consultant for Innovitech before specializing in the valorization and commercialization of university technologies with Univalor. Before taking over the management of both valorization companies, Gestion Valeo and MSBi Valorisation, in order to regroup their activities in the new Aligo company, she held the position of Director of Business Development at Héma-Québec. She concluded numerous licence agreements, participated in the financing of projects and the startup of many technological companies. She currently sits on the Board of Directors of ACFAS, Groupe 3737, CRIM and Laurent Pharmaceuticals, as well as on the Executive Committee of Oncopole.